- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03446300
Shanghai High Myopia Study for Adults (SHMSA)
February 20, 2018 updated by: Shanghai Eye Disease Prevention and Treatment Center
The Cohort Study of Early Visual Impairment Mechanism Caused by Change of Fundus Structure in Adults With High Myopia
High myopia retinopathy has become the first cause of irreversible blindness and severe visual impairment in Chinese adults, in order to avoid the blind and visual impairment caused by high myopia retinopathy, it is very necessary to research the mechanism of early visual impairment to prevent and control damages.
Our recent research found that the decreasing of macular retina vascular density and subfoveal choroidal thickness, the increasing of Beta Zone area in optic atrophy and the rising of glycosylated hemoglobin in high myopia patients were significantly related to visual impairment, which suggested that the source of visual impairment was the abnormal structure changes surrounding optic and fovea, but so far there is no related study.
We will conduct a 5 years prospective cohort study in the population of 2420 high myopia and controls which have established in college student population, working population and aged more than 50 years old population, using the latest OCT-A and SS-OCT to measure macular retina vascular density, subfoveal choroidal thickness, Beta Zone area in optic atrophy, combined with the semiparametric mixed effects model, we will analysis the prediction index between fundus structure parameters, blood biochemical index and individual characteristics prediction to explore the public health management mode of early prevention and treatment during high myopia population.
Study Overview
Status
Unknown
Conditions
Study Type
Observational
Enrollment (Anticipated)
2000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Shanghai
-
Shanghai, Shanghai, China, 200040
- Recruiting
- Shanghai Eye Disease Prevention & Treatment Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 100 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
college student population; working population; aged more than 50 years old population.
Description
Inclusion Criteria:
- ≥18 years old; spherical equivalent refraction ≤-6.00D;
Exclusion Criteria:
- a history of ocular or systemic diseases including congenital cataract and glaucoma; previous intraocular or refractive surgery;other evidence of retinal pathology
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
college student population
|
|
working population
|
|
aged more than 50 years old population
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Retina Vessel Density (RVD)
Time Frame: December 31, 2016
|
RVD is calculated both the macular and peripapillary area.
|
December 31, 2016
|
|
tilted optic disc
Time Frame: December 31, 2016
|
A tilted optic disc was defined as the tilt ratios ≤0.80.
|
December 31, 2016
|
|
β-zone PPA
Time Frame: December 31, 2018
|
The β-zone PPA area (an inner crescent of chorioretinal atrophy with good visibility of the large choroidal vessels and the sclera) was determined as the total number of pixels using the ImageJ software in a circumferential pattern.
|
December 31, 2018
|
|
glycosylated hemoglobin
Time Frame: December 31, 2020
|
This test measures the average blood sugar control for the previous three months or so.
|
December 31, 2020
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Jianfeng Zhu, PhD, MD, Shanghai Eye Disease Prevention & Treatment Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
January 1, 2016
Primary Completion (ANTICIPATED)
December 31, 2019
Study Completion (ANTICIPATED)
December 31, 2020
Study Registration Dates
First Submitted
February 10, 2018
First Submitted That Met QC Criteria
February 20, 2018
First Posted (ACTUAL)
February 26, 2018
Study Record Updates
Last Update Posted (ACTUAL)
February 26, 2018
Last Update Submitted That Met QC Criteria
February 20, 2018
Last Verified
February 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- YFZX2018002
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on High Myopia
-
Shanghai Eye Disease Prevention and Treatment CenterShanghai General Hospital, Shanghai Jiao Tong University School of MedicineEnrolling by invitationHigh Myopia | Pathologic MyopiaChina
-
Shanghai Eye Disease Prevention and Treatment CenterEssilor InternationalNot yet recruiting
-
Shanghai Eye Disease Prevention and Treatment CenterShanghai General Hospital, Shanghai Jiao Tong University School of Medicine; Shandong University of Traditional Chinese MedicineNot yet recruiting
-
Tianjin Eye HospitalActive, not recruitingMyopia | High MyopiaChina
-
Beijing Tongren HospitalTsinghua UniversityActive, not recruiting
-
Assiut UniversityCompleted
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityUnknown
-
Instituto de Olhos de GoianiaCompleted